Compare · MTD vs NAUT
MTD vs NAUT
Side-by-side comparison of Mettler-Toledo International Inc. (MTD) and Nautilus Biotechnology Inc. (NAUT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MTD and NAUT operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- MTD is the larger of the two at $32.84B, about 119.5x NAUT ($274.9M).
- NAUT has been more active in the news (3 items in the past 4 weeks vs 2 for MTD).
- MTD has more recent analyst coverage (25 ratings vs 9 for NAUT).
- Company
- Mettler-Toledo International Inc.
- Nautilus Biotechnology Inc.
- Price
- $1621.41-1.12%
- $2.06-4.19%
- Market cap
- $32.84B
- $274.9M
- 1M return
- -
- +112.15%
- 1Y return
- -
- +110.89%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 1997
- 2020
- News (4w)
- 2
- 3
- Recent ratings
- 25
- 9
Mettler-Toledo International Inc.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform. The company's industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Nautilus Biotechnology Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the human proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company is headquartered in Seattle, Washington.
Latest MTD
- Mettler-Toledo International Inc. to Host Investor Meeting
- Mettler-Toledo International Inc. to Host Third Quarter 2026 Earnings Conference Call
- UBS resumed coverage on Mettler-Toledo with a new price target
- Rothschild & Co Redburn initiated coverage on Mettler-Toledo with a new price target
- Director Shuman-Fabbri Natalia was granted 16 shares (SEC Form 4)
- RBC Capital Mkts initiated coverage on Mettler-Toledo with a new price target
- President and CEO Kaltenbach Patrick exercised 942 shares at a strike of $1,024.55 and sold $1,342,350 worth of shares (942 units at $1,425.00) (SEC Form 4)
- Director Salice Thomas P exercised 417 shares at a strike of $397.95 and sold $600,651 worth of shares (417 units at $1,440.41) (SEC Form 4)
- Director Salice Thomas P exercised 415 shares at a strike of $397.95 and sold $599,517 worth of shares (415 units at $1,444.62) (SEC Form 4)
- Head of Process Analytics Keller Gerry exercised 240 shares at a strike of $720.81 and sold $342,514 worth of shares (240 units at $1,427.14) (SEC Form 4)
Latest NAUT
- Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
- Roth Capital initiated coverage on Nautilus Biotechnology with a new price target
- SEC Form EFFECT filed by Nautilus Biotechnology Inc.
- SEC Form 424B5 filed by Nautilus Biotechnology Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Nautilus Biotechnology Inc.
- Nautilus Biotechnology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form S-3 filed by Nautilus Biotechnology Inc.
- Leerink Partners initiated coverage on Nautilus Biotechnology with a new price target
- Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
- Amendment: SEC Form SCHEDULE 13D/A filed by Nautilus Biotechnology Inc.